At CRISPR Therapeutics, we are focused on developing transformative gene-based medicines for serious human diseases
We are rapidly translating our specific, efficient and versatile CRISPR/Cas9 gene-editing platform into therapies to treat hemoglobinopathies, cancer, diabetes and other diseases
Our multi-disciplinary team of world-class researchers and drug developers works every day to translate our CRISPR/Cas9 technology into breakthrough human therapeutics. We are advancing a variety of programs across our four core franchises: hemoglobinopathies, immuno-oncology, regenerative medicine, and in vivo.
-
Can climate‑risk farming improve nutri
As the planet warms and weather patterns beco.
-
What brain striatum mapping means for co
When researchers say they are “mapping the .
-
How digital twins can personalize longev
Imagine a virtual replica of your body that k.
